Zhixiong Liu

National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019–2020

Identification of a single cell-based signature for predicting prognosis risk and immunotherapy response in patients with glioblastoma

NCBP1 Improves Cognitive Function in Mice by Reducing Oxidative Stress, Neuronal Loss, and Glial Activation After Status Epilepticus

Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis

Glioma targeted therapy: insight into future of molecular approaches

Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts

Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma

Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma

Tumor buster - where will the CAR-T cell therapy ‘missile’ go?

<scp>PTX3</scp> mediates the infiltration, migration, and inflammation‐resolving‐polarization of macrophages in glioblastoma

Hyaluronic acids mediate the infiltration, migration, and <scp>M2</scp> polarization of macrophages: evaluating metabolic molecular phenotypes in gliomas

Molecular diagnosis and treatment of meningiomas: an expert consensus (2022)

Pericyte mediates the infiltration, migration, and polarization of macrophages by CD163/MCAM axis in glioblastoma

Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer

Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment

PTX3 Mediates the Infiltration, Migration, and M2-Polarization of Macrophages in Glioblastoma by Large-Scale Single Cell Sequencing Analysis and in vitro Experiments

Immunotherapy for glioma: Current management and future application

Clinical practice guidelines for the management of adult diffuse gliomas

A novel integrated system using patient-derived glioma cerebral organoids and xenografts for disease modeling and drug screening

Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients

Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma‐related epilepsy

Protein Disulfide Isomerases Are Promising Targets for Predicting the Survival and Tumor Progression in Glioma Patients

CGCG clinical practice guidelines for the management of adult diffuse gliomas

Drug Discovery via Human-Derived Stem Cell Organoids